Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Can… Recruiting

2023-507914-28-00 Platinum-resistant, high-grade serous ovarian cancer (O 10 2024-06-19
A Phase 1 study of JNJ-87704916, a tumor-targeting virus, injected into tumor for advanced cancer Recruiting

2023-506495-27-00 Advanced solid tumors 1 2024-06-18
A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in Participants… Recruiting

2022-501697-19-01 Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Ly 5 2024-06-18
A study of ASP2138 given by itself or given with other cancer treatments in adults with stomach cancer, gastroesophageal junction cancer, or… Recruiting

2023-504514-29-00 Gastroesophageal Junction (GEJ) Adenocarcinoma 1 2024-06-18
Choice Of the Most Active Strategies for Short term recurring Triple Negative Breast Cancer A phase Ib/II, open-label, modular, dose-finding… Recruiting

2023-503606-36-00 Patients with hormone-receptor negative and HER2-negati 9 2024-06-17
Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with long-acting Somatostatin Analogues – ATSA trial Recruiting

2023-505884-35-00 The study population includes all patients aged over 18 6 2024-06-17
A clinical study of bomedemstat for people in a prior bomedemstat study Recruiting

2023-506996-89-00 Myeloproliferative Neoplasms (Essential Thrombocythemia 5 2024-06-13
FIRST-NEC - A multicenter phase II study evaluating the efficacy and safety of the combination of durvalumab (MEDI 4736) with etoposide and … Recruiting

2023-506590-35-00 Large-Cell NeuroEndocrine Carcinoma of the lung 4 2024-06-13
NOvel Immunotherapy strategies for advanced Triple negative breast Cancer (TNBC) patients: TONIC-3 trial Recruiting

2023-507875-23-00 advanced TNBC, eg. irresectable recurrent disease or m 4 2024-06-12
Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left … Recruiting

2023-509551-14-00 Unresectable left sided RAS/B-RAF wild-type metastatic 5 2024-06-12
PreVent-ACaLL Recruiting

2024-511072-33-00 Chronic Lymphocytic Leukemia 4 2024-06-12
A phase II study of preoperative stereotactic radiation therapy boost combined with short-course immunotherapy (pembrolizumab versus placebo… Recruiting

2023-504145-31-00 HER2 negative breast cancer 4 2024-06-10
A Phase III Randomized Controlled Multicentre Trial of Percutaneous Hepatic Perfusion in Combination with Ipilimumab and Nivolumab Compared … Recruiting

2023-508156-20-00 Uveal Melanoma Liver Metastases 5 2024-06-10
Phase 2, randomised study of Radspherin® in patients with primary advanced epithelial cancer with peritoneal metastasis that are homologous … Recruiting

2023-508497-28-00 Carcinomatosis of peritoneal cavity 4 2024-06-05
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX versus mFOLFIRINOX Alone in Patients wit… Recruiting

2022-502404-73-00 Pancreatic ductal adenocarcinoma 4 2024-06-03
MorningLyte: Evaluation of the benefits of the combination of mosunetuzumab plus lenalidomide versus a treatment with anti-CD20 monoclonal a… Recruiting

2023-505436-35-00 Untreated FLIPI 2-5 Follicular Lymphoma 5 2024-06-03
A clinical study to test the effect of niraparib and immunotherapy, for patients with small cell lung cancer (SCLC) that is positive for SLF… Recruiting

2022-502092-33-00 Extensive-disease small cell lung cancer and high SLFN1 4 2024-05-31
Phase 1, First-in-Human Study to Assess the Safety, Tolerability and Anti-tumor Activity of CDR404 in HLA-A*02:01 Participants with MAGE-A4 … Recruiting

2023-508808-38-00 Solid tumors 1 2024-05-29
A Phase 3 study of Dostarlimab as Sequential Therapy after Chemoradiation compared to placebo in adult participants with Locally Advanced Un… Recruiting

2023-508613-17-00 Neoplasms, Head and Neck 5 2024-05-29
A Phase 1b/2 Study of BGB-11417 as Monotherapy and in Various Combinations with Dexamethasone plus Carfilzomib, Dexamethasone plus Daratumum… Recruiting

2023-507751-30-00 relapsed or refractory multiple myeloma 9 2024-05-27
EstroTEP and circulating biomarkers for ER-positive HER2-negative metastatic breast cancer patients Recruiting

2023-506282-66-00 Women with ER+ HER2- metastatic breast cancer who progr 5 2024-05-27
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE) Recruiting

2023-504251-27-00 Locally Advanced or Metastatic Solid Tumors Harboring a 7 2024-05-27
Clinical trial of trabectedin and low-dose radiation therapy in advanced/metastatic sarcomas Recruiting

2023-509215-81-00 Adult and young adult patients with diagnosis of advanc 4 2024-05-22
A Single-Arm, Open-Label, Multicenter, Phase 1b/2 Study Evaluating the Safety and Efficacy of AUTO1 (obecabtagene autoleucel [obe-cel]) in P… Recruiting

2023-506307-26-00 B-cell Acute Lymphoblastic Leukemia (B ALL) and Aggress 3 2024-05-22